ID: ALA506096

Max Phase: Preclinical

Molecular Formula: C25H34FN3O9P2S

Molecular Weight: 633.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)SCCCC(P(=O)(O)O)P(=O)(O)O)cn(C3CC3)c12

Standard InChI:  InChI=1S/C25H34FN3O9P2S/c1-38-24-21-16(10-18(26)22(24)28-11-14-4-2-8-27-19(14)13-28)23(30)17(12-29(21)15-6-7-15)25(31)41-9-3-5-20(39(32,33)34)40(35,36)37/h10,12,14-15,19-20,27H,2-9,11,13H2,1H3,(H2,32,33,34)(H2,35,36,37)/t14-,19+/m0/s1

Standard InChI Key:  WNBWTJHJRBKAOB-IFXJQAMLSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bone 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 633.57Molecular Weight (Monoisotopic): 633.1475AlogP: 3.01#Rotatable Bonds: 10
Polar Surface Area: 178.63Molecular Species: ZWITTERIONHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.21CX Basic pKa: 9.44CX LogP: -0.64CX LogD: -2.74
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: 0.07

References

1. Tanaka KS, Houghton TJ, Kang T, Dietrich E, Delorme D, Ferreira SS, Caron L, Viens F, Arhin FF, Sarmiento I, Lehoux D, Fadhil I, Laquerre K, Liu J, Ostiguy V, Poirier H, Moeck G, Parr TR, Rafai Far A..  (2008)  Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.,  16  (20): [PMID:18815051] [10.1016/j.bmc.2008.09.010]

Source